| Drug Name: | Tripelennamine (91-81-6) |
|---|---|
| PubChem ID: | 5587 |
| SMILES: | CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2 |
| InchiKey: | UFLGIAIHIAPJJC-UHFFFAOYSA-N |
| Therapeutic Category: | Anti-Allergic Agents, Histamine Agents, Histamine Antagonists, Histamine H1 Antagonists, Neurotransmitter Agents |
| Molecular Weight (dalton) | : | 255.365 |
| LogP | : | 2.6498 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 19.37 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Insomnia | Mitogen-activated protein kinase 3 (P27361) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category